This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
medications; investigations; and out-patient visits. Hospital resource use was from staff-completed forms and other resource use was from patient-completed forms. The unit costs were from the Scottish health service, the manufacturers of the equipment, a compendium of health and social care costs, the British National Formulary, and NHS Reference Costs. As the equipment could be used over many years, its costs were converted into equivalent annual costs at a 3.5% discount rate and assuming it would last 10 years. The patient costs included their time away from usual activities and that of a friend or family to attend health care visits. This information was collected by postal questionnaire. Travel costs were based on public transport or actual mileage. Time was valued using the average wage for employed women, 57% of average wage for housework, and 43% of average wage for leisure. The price year was 2006. All costs were reported in UK pounds sterling (£).
Analysis of uncertainty:
Non-parametric bootstrapping, with 1,000 simulations, was used to estimate the confidence intervals around the difference in the mean total cost, and mean QALYs. The results were presented in a cost-effectiveness acceptability curve. One-way sensitivity analyses were performed using plausible cost ranges and varying the methods used to calculate the costs.
Results
The average NHS cost was £758.46 per patient for the thermal balloon group compared with £576 for the microwave group; a difference of £181 per patient. The average QALYs gained were 0.86 for the thermal balloon group compared with 0.87 for the microwave group; a difference of 0.017 per patient (not significant).
The NHS costs were combined with the QALYs and microwave ablation was dominant over thermal balloon ablation as it was more effective and cheaper. At a £20,000 per QALY threshold, the probability that microwave ablation was costeffective compared with thermal balloon ablation was 93%, from the NHS perspective.
The average patient plus companion cost was £333.35 for the thermal balloon group compared with £494.27 for the microwave group; a non-significant difference of £160.92.
